MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹199 Cr | ₹90 Cr | ₹44 Cr | ₹37 Cr | ₹35 Cr |
What is the latest Total Non-Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹199 Cr |
| Mar2025 | ₹90 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹35 Cr |
How is Total Non-Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹199 Cr | 119.62 | |
| Mar2025 | ₹90 Cr | 105.96 | |
| Mar2024 | ₹44 Cr | 19.11 | |
| Mar2023 | ₹37 Cr | 3.91 | |
| Mar2022 | ₹35 Cr | - | |
Compare Total Non-Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,055.3 Cr | -9.1% | -21.7% | 98.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -9.1% |
-21.7% |
98.4% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses